Condition
Synucleinopathy
Total Trials
4
Recruiting
2
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (1)
P 2 (2)
Trial Status
Active Not Recruiting2
Recruiting2
Clinical Trials (4)
Showing 4 of 4 trials
NCT07533799Recruiting
The Swedish BioFINDER Sleep Study
NCT07480187Not ApplicableActive Not Recruiting
Toward Molecular Profiling of Parkinson's Disease in Easily Accessible Biological Matrices
NCT04534023Phase 2Active Not Recruiting
A Clinical Study of the Efficacy of Idebenone in the Treatment of iRBD Into Synucleinopathies
NCT06460038Phase 2RecruitingPrimary
Tenapanor in Synucleinopathy-Related Constipation
Showing all 4 trials